Keyphrases
Tumor Progression
100%
Triple-negative Breast Cancer
100%
Tumor Metastasis
100%
Sclerostin
100%
Tumor Growth
38%
Aptamer
30%
Triple-negative Breast Cancer Cells
30%
Inhibitory Effect
23%
Migration Invasion
23%
Orthotopic Model
15%
Metastatic Mouse Model
15%
Molecular Targets
7%
Osteoporosis
7%
Cell Proliferation
7%
Cellular Uptake
7%
Drug Target
7%
Well-defined
7%
Metastatic Breast Cancer
7%
Fluorescence Microscopy
7%
Breast Cancer Patients
7%
Invasive Ability
7%
Migratory Ability
7%
Secreted Proteins
7%
MDA-MB-231
7%
Osteocyte
7%
Transwell Assay
7%
Colony Formation Assay
7%
Nucleic Acids
7%
WT Mice
7%
Breast Cancer Progression
7%
Breast Cancer Cell Lines
7%
Antibody IgG
7%
Breast Cancer Subtypes
7%
Worse Prognosis
7%
Aggressive Subtypes
7%
Proliferative Activity
7%
Anti-sclerostin Antibody
7%
Antibody Treatment
7%
Sclerostin Antibody
7%
Single Strand
7%
Breast Cancer Tissues
7%
Sclerostin Expression
7%
Limited Treatment Options
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Triple Negative Breast Cancer
100%
Metastasis
100%
Sclerostin
100%
Aptamer
25%
Mouse Model
12%
Breast Cancer
12%
Molecular Target
6%
Wild Type Mouse
6%
Cancer Growth
6%
Fluorescence Microscopy
6%
Nucleic Acid
6%
Immunology and Microbiology
Cancer Cell
100%
Mouse Model
66%
Cell Proliferation
33%
Wild Type Mouse
33%
Colony Formation
33%
Osteocyte
33%
Fluorescence Microscopy
33%
Breast Cancer Cell Line
33%
Cancer Tissue
33%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Sclerostin
100%
Aptamer
25%
Cancer Cell
25%
Mouse Model
12%
Cell Proliferation
6%
Wild Type Mouse
6%
Fluorescence Microscopy
6%
Colony Formation
6%
Osteocyte
6%
Nucleic Acid
6%